Giant-cell tumor of bone: treatment options and role of denosumab
Arun S Singh,1 Neal S Chawla,2 Sant P Chawla2 1Sarcoma Service, Division of Hematology/Oncology, University of California, Los Angeles, 2Sarcoma Oncology Center, Santa Monica, CA, USA Abstract: Giant-cell tumor of bone is a rare, locally aggressive tumor that typically occurs in the bones of skelet...
Guardado en:
Autores principales: | Singh AS, Chawla NS, Chawla SP |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Dove Medical Press
2015
|
Materias: | |
Acceso en línea: | https://doaj.org/article/63d3a940dabe42b59981387a6eea2a4f |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Role of denosumab in the management of skeletal complications in patients with bone metastases from solid tumors
por: Stopeck AT, et al.
Publicado: (2012) -
Tumor microenvironment in giant cell tumor of bone: evaluation of PD-L1 expression and SIRPα infiltration after denosumab treatment
por: Yu Toda, et al.
Publicado: (2021) -
Denosumab: an investigational drug for the management of postmenopausal osteoporosis
por: E Michael Lewiecki
Publicado: (2008) -
Dramatic response of aneurysmal bone cyst to denosumab: Case report and literature review
por: Pedram Fadavi, et al.
Publicado: (2021) -
Denosumab, a RANK ligand inhibitor, for the management of bone loss in cancer patients
por: Yee AJ, et al.
Publicado: (2012)